POTENTIAL LINK BETWEEN DIETARY-INTAKE OF FATTY-ACIDS AND BEHAVIOR - PILOT EXPLORATION OF SERUM-LIPIDS IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER

被引:21
作者
ARNOLD, LE
KLEYKAMP, D
VOTOLATO, N
GIBSON, RA
HORROCKS, L
机构
[1] Ohio State University, Child and Adolescent Disorders Research Branch, National Institute on Mental Health
[2] Wright State University, Dayton, Ohio
[3] Ohio State University, Columbus, Ohio
[4] Flinders Medical Centre, Adelaide, South Australia
关键词
D O I
10.1089/cap.1994.4.171
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Essential fatty acids are structural components of all biological membranes and form the environment for membrane receptors, ion channels, and enzymes. Dietary linoleic acid is metabolized by delta-6-desaturase to gamma-linolenic acid (GLA). Through several further metabolic steps, GLA is eventually converted to series-1 prostaglandins, thromboxanes, and other molecules involved in regulating the moment-to-moment function of various physiological processes. For example, prostaglandins interact with dopamine neurotransmission. The biochemistry and physiology of essential fatty acids are reviewed, with attention to possible implications for behavior. Delta-6-desaturase deficiency has been hypothesized to be one cause of attention-deficit hyperactivity disorder (ADHD). To explore this possibility, we examined the correlations of serum lipids and behavior in a double-blind crossover comparison of GLA, d-amphetamine, and placebo in 16 boys (ages 6-12) with ADHD. Looking at the fatty-acid components of serum triglycerides across treatment conditions, we found that higher scores for behavior problems correlated with lower levels of GLA (for each of four behavioral ratings, p < 0.015) but not with its precursor, linoleic acid. This is compatible with a metabolic bottleneck at delta-6-desaturase being related to some ADHD symptoms. These preliminary findings are consistent with the possibility that fatty-acid intake or metabolism may influence behavior, at least in children with ADHD, and could conceivably modulate the effects of psychopharmacological treatment. This study must be considered exploratory and heuristic, and more definitive studies are needed to examine the possible relevance of fatty-acid metabolism to psychiatric disorders.
引用
收藏
页码:171 / 182
页数:12
相关论文
共 45 条
[21]  
Hwang T.C., Guggino S.E., Guggino W.B., Direct modulation of secretory chloride channels by arachidonic and other eis unsaturated fatty acids, Proc Nati Acad Sci USA, 87, pp. 5706-5709, (1990)
[22]  
Kim D., Clapham D.E., Potassium channels in cardiac cells activated by arachidonic acid and phospholipids, Science, 244, pp. 1174-1176, (1989)
[23]  
McPhail L.A., Clayton C.C., Snyderman R., A potential second messenger role for unsaturated fatty acids: Activation of Ca<sup>2+</sup>-dependent protein kinase, Science, 224, pp. 622-625, (1984)
[24]  
Mitchell E.A., Aman M.G., Turbott S.H., Manku M., Clinical characteristics and serum essential fatty acid levels in hyperactive children, Clin Fed, 26, pp. 406-411, (1987)
[25]  
Mitsuhashi N., Takano A., Kato J., Inhibition of the binding of R-5020 and rat uterine progesterone receptors by long chain fatty acids, Endocrinol Jpn, 33, pp. 251-256, (1983)
[26]  
Molderings G., Malinowska B., Schlicker E., Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP<sub>3</sub>-subtype, Brit J Pharmacol, 107, pp. 352-355, (1992)
[27]  
Nadasy G.L., Szekacs B., Juhasz I., Monos E., Pharmacological modulation of prostacyclin and thromboxane production of rat and cat venous tissue slices, Prostaglandins, 44, pp. 339-355, (1992)
[28]  
Negishi M., Ito S., Prostaglandin E2-induced arachidonic acid release and catecholamine secretion from cultured bovine adrenal chromaffin cells, Biochem Pharmacol, 44, pp. 2315-2321, (1992)
[29]  
Neuringer M., Anderson G.J., Connor W.E., The essentiality of n-3 fatty acids for the development and function of the retina and brain, Annu Rev Nutr, 8, pp. 517-541, (1988)
[30]  
Ono N., Abiru T., Sugiyama K., Kamiya H., Influences of cyclooxygenase inhibitors on the cataleptic behavior induced by haloperidol in mice, Prostaglandins, Leukot, Essent Fatty Acids, 46, pp. 59-63, (1992)